GNMX
Aevi Genomic Medicine Inc
GNMX
GNMX
Delisted
GNMX was delisted on the 3rd of February, 2020.
43 hedge funds and large institutions have $45.8M invested in Aevi Genomic Medicine Inc in 2015 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
13% more funds holding
Funds holding: 38 → 43 (+5)
Holders
43
Holding in Top 10
1
Calls
$164K
Puts
$107K
Top Buyers
| 1 | +$1.01M | |
| 2 | +$573K | |
| 3 | +$314K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$306K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$273K |
Top Sellers
| 1 | -$403K | |
| 2 | -$182K | |
| 3 | -$101K | |
| 4 |
Jennison Associates
New York
|
-$99.8K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$87K |